Annual EBIT
-$33.33 M
-$10.06 M-43.22%
July 31, 2024
Summary
- As of February 20, 2025, BCTX annual earnings before interest & taxes is -$33.33 million, with the most recent change of -$10.06 million (-43.22%) on July 31, 2024.
- During the last 3 years, BCTX annual EBIT has fallen by -$19.59 million (-142.62%).
- BCTX annual EBIT is now -387459.30% below its all-time high of -$8600.00, reached on July 31, 2006.
Performance
BCTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.15 M
+$615.20 K+10.67%
October 31, 2024
Summary
- As of February 20, 2025, BCTX quarterly earnings before interest & taxes is -$5.15 million, with the most recent change of +$615.20 thousand (+10.67%) on October 31, 2024.
- Over the past year, BCTX quarterly EBIT has stayed the same.
- BCTX quarterly EBIT is now -146.17% below its all-time high of $11.16 million, reached on January 31, 2022.
Performance
BCTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$29.98 M
+$3.35 M+10.05%
October 31, 2024
Summary
- As of February 20, 2025, BCTX TTM earnings before interest & taxes is -$29.98 million, with the most recent change of +$3.35 million (+10.05%) on October 31, 2024.
- Over the past year, BCTX TTM EBIT has stayed the same.
- BCTX TTM EBIT is now -2132.39% below its all-time high of $1.48 million, reached on April 30, 2021.
Performance
BCTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.2% | 0.0% | 0.0% |
| 3 y3 years | -142.6% | 0.0% | 0.0% |
| 5 y5 years | -611.1% | 0.0% | 0.0% |
BCTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -142.6% | at low | -146.2% | +48.5% | -536.7% | +29.5% |
| 5 y | 5-year | -734.3% | at low | -146.2% | +81.3% | -2132.4% | +29.5% |
| alltime | all time | <-9999.0% | at low | -146.2% | +81.3% | -2132.4% | +29.5% |
BriaCell Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$5.15 M(-10.7%) | -$29.98 M(-10.1%) |
| Jul 2024 | -$33.33 M(+43.2%) | -$5.77 M(-37.5%) | -$33.33 M(-5.5%) |
| Apr 2024 | - | -$9.23 M(-6.1%) | -$35.27 M(+11.2%) |
| Jan 2024 | - | -$9.83 M(+15.6%) | -$31.72 M(+20.3%) |
| Oct 2023 | - | -$8.50 M(+10.3%) | -$26.37 M(+13.3%) |
| Jul 2023 | -$23.27 M(-13.3%) | -$7.71 M(+35.7%) | -$23.27 M(+45.3%) |
| Apr 2023 | - | -$5.68 M(+26.5%) | -$16.02 M(-21.3%) |
| Jan 2023 | - | -$4.49 M(-17.0%) | -$20.36 M(+332.3%) |
| Oct 2022 | - | -$5.40 M(+1099.6%) | -$4.71 M(-82.5%) |
| Jul 2022 | -$26.84 M(+95.4%) | -$450.40 K(-95.5%) | -$26.84 M(-36.9%) |
| Apr 2022 | - | -$10.02 M(-189.7%) | -$42.54 M(+44.1%) |
| Jan 2022 | - | $11.16 M(-140.5%) | -$29.51 M(-27.8%) |
| Oct 2021 | - | -$27.53 M(+70.4%) | -$40.86 M(+197.5%) |
| Jul 2021 | -$13.74 M(+243.9%) | -$16.15 M(-636.3%) | -$13.74 M(-1031.3%) |
| Apr 2021 | - | $3.01 M(-1684.5%) | $1.48 M(-172.4%) |
| Jan 2021 | - | -$190.10 K(-53.1%) | -$2.04 M(-37.7%) |
| Oct 2020 | - | -$405.60 K(-56.9%) | -$3.27 M(-20.5%) |
| Jul 2020 | -$4.00 M(-14.8%) | -$941.30 K(+87.7%) | -$4.11 M(-14.9%) |
| Apr 2020 | - | -$501.40 K(-64.7%) | -$4.84 M(-11.5%) |
| Jan 2020 | - | -$1.42 M(+13.8%) | -$5.46 M(+4.3%) |
| Oct 2019 | - | -$1.25 M(-24.9%) | -$5.24 M(+9.6%) |
| Jul 2019 | -$4.69 M(+13.3%) | -$1.66 M(+47.3%) | -$4.78 M(-2.2%) |
| Apr 2019 | - | -$1.13 M(-5.7%) | -$4.89 M(+0.4%) |
| Jan 2019 | - | -$1.20 M(+51.9%) | -$4.87 M(+9.2%) |
| Oct 2018 | - | -$788.30 K(-55.5%) | -$4.46 M(+6.9%) |
| Jul 2018 | -$4.14 M(+60.2%) | -$1.77 M(+59.4%) | -$4.17 M(+19.9%) |
| Apr 2018 | - | -$1.11 M(+41.2%) | -$3.48 M(+7.8%) |
| Jan 2018 | - | -$787.30 K(+57.6%) | -$3.23 M(+16.2%) |
| Oct 2017 | - | -$499.60 K(-53.8%) | -$2.78 M(+6.7%) |
| Jul 2017 | -$2.58 M(+55.0%) | -$1.08 M(+25.7%) | -$2.60 M(+50.6%) |
| Apr 2017 | - | -$859.50 K(+154.2%) | -$1.73 M(+51.4%) |
| Jan 2017 | - | -$338.10 K(+4.0%) | -$1.14 M(-27.7%) |
| Oct 2016 | - | -$325.00 K(+58.1%) | -$1.58 M(+0.8%) |
| Jul 2016 | -$1.67 M(-38.9%) | -$205.60 K(-24.6%) | -$1.57 M(+5.0%) |
| Apr 2016 | - | -$272.50 K(-64.9%) | -$1.49 M(-7.1%) |
| Jan 2016 | - | -$775.30 K(+148.1%) | -$1.61 M(-44.1%) |
| Oct 2015 | - | -$312.50 K(+138.2%) | -$2.87 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jul 2015 | -$2.73 M(+523.7%) | -$131.20 K(-66.0%) | -$2.61 M(-1.7%) |
| Apr 2015 | - | -$386.20 K(-81.1%) | -$2.66 M(+12.1%) |
| Jan 2015 | - | -$2.04 M(+3607.5%) | -$2.37 M(+473.1%) |
| Oct 2014 | - | -$55.00 K(-68.6%) | -$413.40 K(-5.9%) |
| Jul 2014 | -$437.30 K(+3.1%) | -$175.40 K(+75.6%) | -$439.20 K(+23.3%) |
| Apr 2014 | - | -$99.90 K(+20.2%) | -$356.10 K(-5.1%) |
| Jan 2014 | - | -$83.10 K(+2.8%) | -$375.10 K(-6.4%) |
| Oct 2013 | - | -$80.80 K(-12.5%) | -$400.90 K(-6.0%) |
| Jul 2013 | -$424.30 K(-23.1%) | -$92.30 K(-22.4%) | -$426.50 K(-8.0%) |
| Apr 2013 | - | -$118.90 K(+9.2%) | -$463.70 K(-1.4%) |
| Jan 2013 | - | -$108.90 K(+2.3%) | -$470.50 K(-6.5%) |
| Oct 2012 | - | -$106.40 K(-17.8%) | -$503.30 K(-7.9%) |
| Jul 2012 | -$551.80 K(-47.6%) | -$129.50 K(+3.0%) | -$546.70 K(-40.8%) |
| Apr 2012 | - | -$125.70 K(-11.3%) | -$922.80 K(-10.6%) |
| Jan 2012 | - | -$141.70 K(-5.4%) | -$1.03 M(-4.0%) |
| Oct 2011 | - | -$149.80 K(-70.4%) | -$1.08 M(+4.1%) |
| Jul 2011 | -$1.05 M(+224.5%) | -$505.60 K(+114.9%) | -$1.03 M(+81.6%) |
| Apr 2011 | - | -$235.30 K(+27.2%) | -$569.30 K(+13.7%) |
| Jan 2011 | - | -$185.00 K(+71.6%) | -$500.80 K(+36.2%) |
| Oct 2010 | - | -$107.80 K(+161.7%) | -$367.70 K(+16.0%) |
| Jul 2010 | -$324.60 K(+38.8%) | -$41.20 K(-75.3%) | -$316.90 K(-23.8%) |
| Apr 2010 | - | -$166.80 K(+221.4%) | -$416.10 K(+61.2%) |
| Jan 2010 | - | -$51.90 K(-8.9%) | -$258.20 K(+7.4%) |
| Oct 2009 | - | -$57.00 K(-59.4%) | -$240.40 K(+2.0%) |
| Jul 2009 | -$233.90 K(+105.0%) | -$140.40 K(+1477.5%) | -$235.60 K(+55.1%) |
| Apr 2009 | - | -$8900.00(-73.9%) | -$151.90 K(-11.3%) |
| Jan 2009 | - | -$34.10 K(-34.7%) | -$171.30 K(+9.3%) |
| Oct 2008 | - | -$52.20 K(-7.9%) | -$156.70 K(+36.5%) |
| Jul 2008 | -$114.10 K(-11.6%) | -$56.70 K(+100.4%) | -$114.80 K(+17.7%) |
| Apr 2008 | - | -$28.30 K(+45.1%) | -$97.50 K(+18.6%) |
| Jan 2008 | - | -$19.50 K(+89.3%) | -$82.20 K(-23.6%) |
| Oct 2007 | - | -$10.30 K(-73.9%) | -$107.60 K(-14.5%) |
| Jul 2007 | -$129.10 K(+1401.2%) | -$39.40 K(+203.1%) | -$125.80 K(+45.6%) |
| Apr 2007 | - | -$13.00 K(-71.0%) | -$86.40 K(+17.7%) |
| Jan 2007 | - | -$44.90 K(+57.5%) | -$73.40 K(+157.5%) |
| Oct 2006 | - | -$28.50 K | -$28.50 K |
| Jul 2006 | -$8600.00 | - | - |
FAQ
- What is BriaCell Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual EBIT year-on-year change?
- What is BriaCell Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly EBIT year-on-year change?
- What is BriaCell Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BriaCell Therapeutics?
- What is BriaCell Therapeutics TTM EBIT year-on-year change?
What is BriaCell Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BCTX is -$33.33 M
What is the all time high annual EBIT for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual earnings before interest & taxes is -$8600.00
What is BriaCell Therapeutics annual EBIT year-on-year change?
Over the past year, BCTX annual earnings before interest & taxes has changed by -$10.06 M (-43.22%)
What is BriaCell Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BCTX is -$5.15 M
What is the all time high quarterly EBIT for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly earnings before interest & taxes is $11.16 M
What is BriaCell Therapeutics quarterly EBIT year-on-year change?
Over the past year, BCTX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is BriaCell Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BCTX is -$29.98 M
What is the all time high TTM EBIT for BriaCell Therapeutics?
BriaCell Therapeutics all-time high TTM earnings before interest & taxes is $1.48 M
What is BriaCell Therapeutics TTM EBIT year-on-year change?
Over the past year, BCTX TTM earnings before interest & taxes has changed by $0.00 (0.00%)